Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. - Trifilio, S. M.; Bennett, C. L.; Yarnold, P. R.; McKoy, J. M.; Parada, J.; Mehta, J.; Chamilos, G.; Palella, F.; Kennedy, L.; Mullane, K.; Tallman, M. S.; Evens, A.; et al. (Bone Marrow Transplantation, 2007)